Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||2.77%||592.15||2.7%||$478.99m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-0.80%||6.21||0.7%||$434.10m|
|GILD||Gilead Sciences, Inc.||0.09%||67.73||1.0%||$397.88m|
|XLRN||Acceleron Pharma, Inc.||0.00%||173.78||5.3%||$335.39m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.50%||184.07||1.9%||$274.05m|
|XENE||Xenon Pharmaceuticals, Inc.||-0.52%||30.57||0.4%||$164.85m|
|CRSP||CRISPR Therapeutics AG||-1.70%||95.06||0.6%||$159.07m|
Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.